Asian equities traded in the US as American depositary receipts started the week on a high note Mond
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

CoreWeave (CRWV) sells AI computing on NVIDIA GPUs through its own cloud, and demand for its capacity outruns supply. Revenue reached $2.6 billion in the second quarter of 2026, up 112% from a year earlier. The risk is in how that growth gets paid for.

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.
Investors may be overlooking what sits beyond reported debt

PBR expands in Ivory Coast with eight offshore blocks, boosting African exploration footprint as it seeks to replenish reserves.
A new consumer AI signal is changing the conversation
Tech stock news for the week of Sept. 21.

Paramount won’t have to sell cable channels under the $81 billion merger poised to reshape Hollywood.

Anthropic PBC is partnering with Accenture Plc to test the safety of its advanced artificial intelligence models. Evaluators from Accenture will be embedded and tasked with trying to "break" these models before they're deployed. Bloomberg's Ed Ludlow reports.

The S&P 500 has swung back into positive territory for the month, thanks to a rally in tech shares today. Chip stocks, software firms, hyperscalers and shares of companies whose fortunes are tied to cryptocurrencies are all rallying in early trading.
The stock is down sharply from its peak, but Cantor's target implies room to nearly double
Robinhood's CEO believes a federal program that barely exists yet could reshape how Americans build wealth for generations, but independent economists see a very different outcome unfolding.

Expect another earnings beat from Micron next week -- a smaller beat, but still a beat.

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
The deal follows Amodei's own call to slow the pace of frontier development

Pre-Markets in the Green to Start a Fresh Week

Yahoo Finance Executive Editor Brian Sozzi outlines a few unexpected events driving markets this week. For a closer look, watch the video above.

ServiceNow benefits from broad workflow demand, cross-selling and AI partnerships that are fueling growth as competition with CRM and MSFT intensifies.
Pfizer Reveals Surprise HHS Revenue-Sharing Terms in Overseas Drug Pricing Deal

Walmart's SCAN Health Plan collaboration is likely to expand its healthcare offering and deepen engagement with high-spending health and wellness customers.

TEAM's cloud growth, cross-sell gains and agentic automation are driving momentum, while subscription ARR growth is expected to moderate.
Investing.com -- Oppenheimer has cast doubt on the pace of Tesla's Optimus humanoid robot ramp, telling investors that meaningful sales revenue is unlikely before 2029.

The REIT's dividend has fluctuated over the years.

CoreWeave and IREN are scaling AI infrastructure, but capital needs, customer concentration and execution risks shape their outlook.

CAVA's strong first-half free cash flow supports growth investments, but added CapEx and weaker second-half seasonality could moderate cash generation.

The Nest Campus CEO Peter Gilmer joins Kristen Scholer on NYSE Live to Sets the Scene for Its Climate Week Conference

Sept 21 (Reuters) - Paramount Skydance has reached a settlement with California and other states suing to block its $110 billion merger with Warner Bros Discovery, Bloomberg News reported on Monday,

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

NVIDIA and Eli Lilly both shattered expectations this quarter, but picking the better stock for the next decade means choosing between two very different growth machines at very different levels of risk.

Novo Nordisk (NVO) stock is dipping after the company's outlook disappointed investors. Yahoo Finance Executive Editor Brian Sozzi shares his thoughts on the stock, the company's trajectory, and where Eli Lilly (LLY) fits into the equation.